PAR.AX

Paradigm Biopharmaceuticals Limited PAR.AX

PAR.AX
Paradigm Biopharmaceuticals Limited RCE.AX
Recce Pharmaceuticals Ltd ATH.AX
Alterity Therapeutics Limited PEB.AX
Pacific Edge Limited IMU.AX
Imugene Limited ONE.AX
Oneview Healthcare PLC ALA.AX
Arovella Therapeutics Limited EMV.AX
EMVision Medical Devices Ltd SPL.AX
Starpharma Holdings Limited EZZ.AX
EZZ Life Science Holdings Limited

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode PAR.AX RCE.AX ATH.AX PEB.AX IMU.AX ONE.AX ALA.AX EMV.AX SPL.AX EZZ.AX
6M 37.93 % 41.38 % 71.43 % 52.38 % -54.66 % -35.19 % 17.95 % 0.53 % 170.83 % 68.35 %
YTD 0.00 % -16.33 % 33.33 % 18.52 % -72.18 % -40.68 % -45.88 % 1.60 % 136.36 % -10.74 %
1Y 50.94 % -26.79 % 300.00 % 18.52 % -77.84 % -48.53 % -52.82 % -5.45 % 179.57 % -35.75 %
3Y -70.37 % -37.26 % -7.69 % -60.49 % -93.60 % 16.67 % 217.24 % 42.54 % -59.69 % 772.13 %
5Y -86.01 % -64.04 % -73.33 % -89.61 % -80.93 % 328.48 % 124.39 % -35.25 % -82.43 % 129.31 %
10Y 41.39 % 38.03 % -90.00 % -89.61 % 22.00 % -94.39 % -83.37 % 526.23 % -63.89 % 129.31 %
Depuis le début 14.67 % 38.03 % -97.60 % -89.61 % -99.55 % -94.39 % -97.20 % 526.23 % -69.41 % 129.31 %

Dividende

EZZ Life Science Holdings Limited